Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-06

FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for IRBESARTAN from Camber Pharmaceuticals, Inc., approving changes related to this product's use or labeling under a su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)